Patents Assigned to INSERM (INSSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
  • NOVEL MELANOMA ANTIGEN PEPTIDE AND USES THEREOF
    Publication number: 20150291660
    Abstract: The present invention relates to a melanoma antigen peptide comprising the amino acids sequence selected in the group consisting of SEQ ID NO: 1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4 or SEQ ID NO:5 or a function-conservative variant thereof. Moreover the invention also relates to a melanoma antigen peptide according to the invention for use in the prevention or the treatment of melanoma in patient.
    Type: Application
    Filed: May 22, 2012
    Publication date: October 15, 2015
    Applicants: UNIVERSITE D'ANGERS, INSERM (INSSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE D'ANGERS
    Inventors: Nathalie Labarriere, Francois Lang, Mathilde Bobinet, Anne Rogel